WASHINGTON – The government should ban the diabetes drug Avandia because of a wide variety of life-threatening risks, including heart and liver damage, a consumer group said Thursday.The consumer group, Public Citizen, filed a petition with the Food and Drug ...Read More
WASHINGTON (AP) - British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women. The approval from the Food and Drug Administration allows Glaxo to compete against Merck's blockbuster vaccine Gardasil, ...Read More
(Updates with P&G comments and emphasizes which products were implicated). By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The Food and Drug Administration said a warningletter about two Procter & Gamble Co. (PG) Vicks cold products was posted ...Read More
CHICAGO, Oct 14 (Reuters) - The U.S. Food and Drug Administration warned Procter & Gamble Co on Wednesday that its Vicks DayQuil and NyQuil products with vitamin C are misbranded and have false and misleading labeling. The FDA's list of approved ...Read More
Federal drug regulators warned Procter & Gamble on Wednesday for adding Vitamin C to its Vicks cold formulas, a combination not allowed by federal regulations. The Food and Drug Administration said medications like Vicks Nyquil and Dayquil are not permitted to ...Read More
MENLO PARK, Calif.—Corcept Therapeutics Inc. said Tuesday it expects to raise about $18 million by selling stock and options to institutional investors. Corcept said the money will be used to complete enrollment of patients in a late stage clinical trial of ...Read More
The Obama administration is taking on Cheerios. And popular cold remedies and swimming pool drains and rhinestones on children's clothing. With much of Washington focused on efforts to revamp health care and address climate change, a handful of Obama appointees have ...Read More
NEW YORK/PHILADELPHIA (Reuters) - Onyx Pharmaceuticals Inc (ONXX.O) said on Monday it has agreed to buy Proteolix Inc, a privately held biotechnology company developing cancer drugs, for an upfront cash payment of $276 million, sending its shares up more than ...Read More
A UBS analyst on Monday boosted his price target on Amgen Inc., saying the launch of the company's osteoporosis drug denosumab should drive the stock's value. UBS analyst Maged Shenouda reaffirmed a "Buy" rating but now expects shares to reach $70 ...Read More
NEW YORK (AP) - Onyx Pharmaceuticals Inc. said Monday it will buy cancer drug developer Proteolix Inc. in a deal that could be worth as much as $851 million. Onyx will pay $276 million upfront for the privately held South San ...Read More
(Adds information on MS and how fampridine-SR works in the last paragraph and updated stock price.) WASHINGTON (Dow Jones)--A proposed Acorda Therapeutics (ACOR) drug to treat multiple-sclerosis increased walking speed, but U.S. Food and Drug Administration staff questioned whether the improvement ...Read More
WASHINGTON—Shares of Acorda Therapeutics plummeted Friday after the Food and Drug Administration issued a negative opinion that questioned the safety and effectiveness of the company's multiple sclerosis drug. A panel of FDA advisers is scheduled to meet next week to vote ...Read More
Oct. 9 (Bloomberg) -- Acorda Therapeutics Inc.’s multiplesclerosis drug, the first pill to improve walking ability inpatients with the disabling disease, may not be “clinicallymeaningful,” a U.S. review said. The shares fell 13 percent. Food and Drug Administration reviewers said they ...Read More
U.S. stocks rose Friday, with the Dow Jones Industrial Average gaining 21 points to 9808, the Standard & Poor's 500 edging up about 2 points to 1067 and the Nasdaq Composite increasing 8 points to 2132. Among the companies whose ...Read More
WASHINGTON (Dow Jones)--A proposed Acorda Therapeutics (ACOR) drug to treat multiple sclerosis increased walking speed, but U.S. Food and Drug Administration staff questioned whether the improvement was clinically meaningful. The proposed drug fampridine-SR faces a review by an FDA panel of ...Read More
* Drug met main goals of two clinical trials * Secondary review indicated 'very limited effect' * FDA advisers to weigh drug on Wednesday WASHINGTON, Oct 9 (Reuters) - Acorda Therapeutics Inc's(ACOR.O) proposed drug to help multiple sclerosis patients walkbetter appears to have ...Read More
* Says will request meeting with FDA * Says drug non-inferior to current standard drug * Says FDA did not request changes to current indications * Shares fall 17 pct (Recasts, adds details, share movement) Oct 9 (Reuters) - Spectrum Pharmaceuticals (SPPI.O) saidU.S. health ...Read More
BusinessWire - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry(R) (maraviroc) tablets for use in treatment-naive adult patients with CCR5-tropic ...Read More
ADELPHI, Md. - Federal health advisers said Thursday that Pfizer's HIV drug Selzentry should be approved for use by patients who have not already taken other drugs to combat the virus. The Food and Drug Administration's panel of virus experts voted ...Read More
With the release of the Center for Science in the Public Interest's list of the top 10 riskiest foods regulated by the Food and Drug Administration, you may be wondering what's left that is safe to eat and what to ...Read More
NEW YORK (CNNMoney.com) -- Leafy greens -- including lettuce and spinach -- top the list of the 10 riskiest foods, according to a study from a nutrition advocacy group released Tuesday. The Center for Science in the Public Interest listed the ...Read More
